Illumina, Inc. (ILMN)
USD 134.03
(-6.35%)
USD 134.03
(-6.35%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -608 Million USD | -92.59% |
| 2022 | -3.91 Billion USD | 4073.17% |
| 2021 | 747 Million USD | -121.21% |
| 2020 | 767 Million USD | -41.12% |
| 2019 | 1.17 Billion USD | 11.55% |
| 2018 | 1.06 Billion USD | 45.71% |
| 2017 | 780 Million USD | 6.13% |
| 2016 | 735.27 Million USD | -9.84% |
| 2015 | 751.68 Million USD | 70.25% |
| 2014 | 604.74 Million USD | -0.55% |
| 2013 | 363.62 Million USD | 19.8% |
| 2012 | 324.17 Million USD | 9.96% |
| 2011 | 236.09 Million USD | 19.36% |
| 2010 | 251.98 Million USD | 53.57% |
| 2009 | 169.02 Million USD | -4.82% |
| 2008 | 122.59 Million USD | -56.7% |
| 2007 | 18.01 Million USD | 763.86% |
| 2006 | 37.81 Million USD | 207.56% |
| 2005 | -5.51 Million USD | 400.04% |
| 2004 | -4.71 Million USD | 74.42% |
| 2003 | -19.19 Million USD | 24.15% |
| 2002 | -32.35 Million USD | -7.75% |
| 2001 | -22.55 Million USD | -40.62% |
| 2000 | -16.04 Million USD | -229.76% |
| 1999 | -4.86 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 741 Million USD | 144.62% |
| 2024 Q1 | 49 Million USD | 139.53% |
| 2024 Q2 | 589 Million USD | -10988.24% |
| 2023 Q2 | -64 Million USD | 0.0% |
| 2023 Q1 | -64 Million USD | 24.71% |
| 2023 FY | - USD | -92.59% |
| 2023 Q4 | 50 Million USD | -94.36% |
| 2023 Q3 | 886 Million USD | 1484.38% |
| 2022 FY | - USD | 4073.17% |
| 2022 Q4 | -85 Million USD | -102.05% |
| 2022 Q3 | 4.14 Billion USD | 5662.5% |
| 2022 Q2 | 72 Million USD | -69.62% |
| 2022 Q1 | 237 Million USD | 478.05% |
| 2021 Q1 | 193 Million USD | 46.21% |
| 2021 Q2 | 187 Million USD | -3.11% |
| 2021 Q4 | 41 Million USD | 107.52% |
| 2021 Q3 | -545 Million USD | -391.44% |
| 2021 FY | - USD | -121.21% |
| 2020 Q3 | 162 Million USD | 68.75% |
| 2020 Q4 | 132 Million USD | -18.52% |
| 2020 FY | - USD | -41.12% |
| 2020 Q1 | 189 Million USD | -29.48% |
| 2020 Q2 | 96 Million USD | -49.21% |
| 2019 Q4 | 268 Million USD | -12.99% |
| 2019 FY | - USD | 11.55% |
| 2019 Q1 | 204 Million USD | 3.55% |
| 2019 Q2 | 205 Million USD | 0.49% |
| 2019 Q3 | 308 Million USD | 50.24% |
| 2018 FY | - USD | 45.71% |
| 2018 Q1 | 218 Million USD | -5.22% |
| 2018 Q2 | 227 Million USD | 4.13% |
| 2018 Q3 | 241 Million USD | 6.17% |
| 2018 Q4 | 197 Million USD | -18.26% |
| 2017 Q1 | 60 Million USD | -58.29% |
| 2017 FY | - USD | 6.13% |
| 2017 Q4 | 230 Million USD | 27.07% |
| 2017 Q3 | 181 Million USD | 42.52% |
| 2017 Q2 | 127 Million USD | 111.67% |
| 2016 FY | - USD | -9.84% |
| 2016 Q4 | 143.85 Million USD | -10.91% |
| 2016 Q1 | 126.2 Million USD | -17.79% |
| 2016 Q3 | 161.47 Million USD | 15.76% |
| 2016 Q2 | 139.49 Million USD | 10.53% |
| 2015 Q1 | 157.75 Million USD | 329.24% |
| 2015 Q4 | 153.52 Million USD | -5.55% |
| 2015 Q2 | 159.55 Million USD | 1.14% |
| 2015 Q3 | 162.54 Million USD | 1.88% |
| 2015 FY | - USD | 70.25% |
| 2014 Q4 | 36.75 Million USD | -73.46% |
| 2014 Q3 | 138.44 Million USD | 31.14% |
| 2014 Q2 | 105.57 Million USD | 15.68% |
| 2014 Q1 | 91.26 Million USD | 34.3% |
| 2014 FY | - USD | -0.55% |
| 2013 FY | - USD | 19.8% |
| 2013 Q4 | 67.95 Million USD | 64.67% |
| 2013 Q3 | 41.26 Million USD | -44.38% |
| 2013 Q2 | 74.19 Million USD | -61.09% |
| 2013 Q1 | 190.68 Million USD | 155.25% |
| 2012 Q4 | 74.7 Million USD | 39.52% |
| 2012 Q1 | 67.66 Million USD | 24.13% |
| 2012 Q3 | 53.54 Million USD | -2.08% |
| 2012 FY | - USD | 9.96% |
| 2012 Q2 | 54.68 Million USD | -19.19% |
| 2011 Q2 | 92.53 Million USD | -9.96% |
| 2011 Q1 | 102.76 Million USD | 27.09% |
| 2011 FY | - USD | 19.36% |
| 2011 Q4 | 54.51 Million USD | 34.47% |
| 2011 Q3 | 40.54 Million USD | -56.19% |
| 2010 FY | - USD | 53.57% |
| 2010 Q2 | 50.5 Million USD | 24.92% |
| 2010 Q3 | 60.12 Million USD | 19.05% |
| 2010 Q1 | 40.42 Million USD | -24.16% |
| 2010 Q4 | 80.86 Million USD | 34.49% |
| 2009 FY | - USD | -4.82% |
| 2009 Q1 | 41.73 Million USD | -7.27% |
| 2009 Q2 | 37.77 Million USD | -9.5% |
| 2009 Q4 | 53.3 Million USD | 58.56% |
| 2009 Q3 | 33.61 Million USD | -10.99% |
| 2008 FY | - USD | -56.7% |
| 2008 Q4 | 45.01 Million USD | -21.64% |
| 2008 Q3 | 57.43 Million USD | 64.77% |
| 2008 Q2 | 34.86 Million USD | 36.91% |
| 2008 Q1 | 25.46 Million USD | -1.98% |
| 2007 Q2 | 16.18 Million USD | -94.85% |
| 2007 Q1 | 314.36 Million USD | 1613.45% |
| 2007 FY | - USD | 763.86% |
| 2007 Q4 | 25.97 Million USD | 33.75% |
| 2007 Q3 | 19.42 Million USD | 19.97% |
| 2006 Q4 | 18.34 Million USD | 9.08% |
| 2006 FY | - USD | 207.56% |
| 2006 Q1 | 465 Thousand USD | -68.24% |
| 2006 Q2 | 7.88 Million USD | 1596.56% |
| 2006 Q3 | 16.81 Million USD | 113.2% |
| 2005 FY | - USD | 400.04% |
| 2005 Q2 | 13.86 Million USD | 2339.1% |
| 2005 Q3 | -555 Thousand USD | -104.0% |
| 2005 Q4 | 1.46 Million USD | 363.78% |
| 2005 Q1 | -619 Thousand USD | -210.34% |
| 2004 Q2 | -1.71 Million USD | -9.75% |
| 2004 Q4 | 561 Thousand USD | 127.95% |
| 2004 Q3 | -2 Million USD | -17.3% |
| 2004 Q1 | -1.55 Million USD | 21.46% |
| 2004 FY | - USD | 74.42% |
| 2003 Q2 | -6.51 Million USD | 5.84% |
| 2003 Q3 | -3.6 Million USD | 46.04% |
| 2003 Q4 | -2.17 Million USD | 41.82% |
| 2003 Q1 | -6.9 Million USD | 91.59% |
| 2003 FY | - USD | 24.15% |
| 2002 Q2 | -14.44 Million USD | -2.28% |
| 2002 Q4 | -80.03 Million USD | -670.78% |
| 2002 Q3 | 13.82 Million USD | 307.46% |
| 2002 Q1 | -6.59 Million USD | 4.12% |
| 2002 FY | - USD | -7.75% |
| 2001 FY | - USD | -40.62% |
| 2001 Q3 | -5.32 Million USD | 2.65% |
| 2001 Q2 | -5.46 Million USD | -11.74% |
| 2001 Q1 | -4.89 Million USD | -5.61% |
| 2001 Q4 | -6.87 Million USD | -29.23% |
| 2000 Q3 | -3.4 Million USD | 11.4% |
| 2000 Q4 | -4.63 Million USD | -36.06% |
| 2000 Q1 | -4.16 Million USD | 0.0% |
| 2000 FY | - USD | -229.76% |
| 2000 Q2 | -3.84 Million USD | 7.69% |
| 1999 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bionano Genomics, Inc. | -213.6 Million USD | -184.639% |
| Prenetics Global Limited | -47.89 Million USD | -1169.414% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -35940.308% |
| CareDx, Inc | -89.65 Million USD | -578.14% |
| Exact Sciences Corporation | 41.87 Million USD | 1551.906% |
| Exagen Inc. | -19.15 Million USD | -3074.437% |
| Inotiv, Inc. | -26.5 Million USD | -2193.82% |
| Guardant Health, Inc. | -433.3 Million USD | -40.317% |
| Biodesix, Inc. | -37.1 Million USD | -1538.682% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -24365.216% |
| Precipio, Inc. | -4.31 Million USD | -13980.593% |
| iSpecimen Inc. | -9.1 Million USD | -6578.589% |
| Natera, Inc. | -383.27 Million USD | -58.632% |
| Aspira Women's Health Inc. | -16.49 Million USD | -3586.859% |
| Standard BioTools Inc. | -54.45 Million USD | -1016.477% |
| 23andMe Holding Co. | -291.87 Million USD | -108.309% |
| Castle Biosciences, Inc. | -45.02 Million USD | -1250.391% |
| Personalis, Inc. | -96.8 Million USD | -528.054% |
| Aclaris Therapeutics, Inc. | -117.56 Million USD | -417.161% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | -6239.249% |
| OpGen, Inc. | -29.51 Million USD | -1960.249% |
| T2 Biosystems, Inc. | -43.87 Million USD | -1285.755% |
| Myriad Genetics, Inc. | -67.8 Million USD | -796.755% |
| ICON Public Limited Company | 1.63 Billion USD | 137.262% |
| NeoGenomics, Inc. | -17.6 Million USD | -3353.172% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -35940.308% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 149.932% |
| RadNet, Inc. | 292.78 Million USD | 307.66% |
| MDxHealth SA | -30.46 Million USD | -1895.536% |
| Psychemedics Corporation | -251 Thousand USD | -242131.076% |
| Check-Cap Ltd. | -17.64 Million USD | -3344.954% |
| Twist Bioscience Corporation | -176.7 Million USD | -244.076% |
| DarioHealth Corp. | -53.49 Million USD | -1036.576% |
| Fulgent Genetics, Inc. | -46.55 Million USD | -1206.066% |
| Sera Prognostics, Inc. | -35.28 Million USD | -1623.014% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | -6113.717% |
| OPKO Health, Inc. | -65.51 Million USD | -828.018% |
| Medpace Holdings, Inc. | 363.15 Million USD | 267.423% |
| Neogen Corporation | 182.59 Million USD | 432.974% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | -6800.695% |
| Prenetics Global Limited | -47.89 Million USD | -1169.414% |
| Mainz Biomed B.V. | -25.01 Million USD | -2330.911% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -7869.271% |
| Trinity Biotech plc | -24.09 Million USD | -2423.031% |
| Neuronetics, Inc. | -22.75 Million USD | -2571.471% |
| Sotera Health Company | 514.14 Million USD | 218.255% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -7869.271% |